{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T07:54:00Z","timestamp":1723017240694},"reference-count":39,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2023-0239","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T03:23:35Z","timestamp":1715397815000},"page":"1201-1210","source":"Crossref","is-referenced-by-count":0,"title":["Tumor microenvironment in Hodgkin lymphoma: novel prognostic factors for assessing disease evolution"],"prefix":"10.25122","volume":"16","author":[{"given":"Marilena","family":"Stoian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Internal Medicine, Dr. I. Cantacuzino Clinical Hospital, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Turbatu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Hematology, Col\u021bea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Dobrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"OncoTeam Diagnostic Laboratory, Royal Hospital Clinic, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian Tudor","family":"Barta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgian","family":"Halcu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Pathology, Col\u021bea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PathoTeam Diagnostic Laboratory, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelina","family":"Birceanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"PathoTeam Diagnostic Laboratory, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Maria","family":"Bordea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Hematology, Col\u021bea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia Gabriela","family":"Ghimici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Hematology, Col\u021bea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u0103d\u0103lina Marilena","family":"Oprea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Hematology, Col\u021bea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia Doria","family":"Neac\u0219u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Hematology, Col\u021bea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca-Roxana","family":"Lupu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Hematology, Col\u021bea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Coli\u021b\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Hematology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Clinic of Hematology, Col\u021bea Clinical Hospital, Bucharest, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2023,8]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3322\/caac.21438.","article-title":"Hodgkin lymphoma: A review and update on recent progress","volume":"68","author":"Shanbhag S Ambinder RF","year":"2018","unstructured":"1. Shanbhag S Ambinder RF Hodgkin lymphoma: A review and update on recent progress CA Cancer J Clin 2018 Mar682116132 10.3322\/caac.21438.","journal-title":"CA Cancer J Clin"},{"issue":"10310","key":"ref2","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/S0140-6736(20)32207-8","article-title":"Classical Hodgkin lymphoma","volume":"398","author":"Brice P de Kerviler E Friedberg JW","year":"2021","unstructured":"2. Brice P de Kerviler E Friedberg JW Classical Hodgkin lymphoma Lancet 2021 Oct 233981031015181527 10.1016\/S0140-6736(20)32207-8","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/hon.2589.","article-title":"Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease","volume":"37","author":"LaCasce AS","year":"2019","unstructured":"3. LaCasce AS Treating Hodgkin lymphoma in the new millennium: Relapsed and refractory disease Hematol Oncol 2019 Jun37 Suppl 18791 10.1002\/hon.2589.","journal-title":"Hematol Oncol"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41572-020-0189-6.","article-title":"Hodgkin lymphoma","volume":"6","author":"Connors JM Cozen W Steidl C Carbone A Hoppe RT Flechtner HH Bartlett NL","year":"2020","unstructured":"4. Connors JM Cozen W Steidl C Carbone A Hoppe RT Flechtner HH Bartlett NL Hodgkin lymphoma Nat Rev Dis Primers 2020 Jul 236161 10.1038\/s41572-020-0189-6.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","first-page":"e2014053","DOI":"10.4084\/MJHID.2014.053.","article-title":"Prognostic factors in hodgkin lymphoma","volume":"6","author":"Cuccaro A Bartolomei F Cupelli E Galli E Giachelia M Hohaus S","year":"2014","unstructured":"5. Cuccaro A Bartolomei F Cupelli E Galli E Giachelia M Hohaus S Prognostic factors in hodgkin lymphoma Mediterr J Hematol Infect Dis 2014 Jul 561e2014053 10.4084\/MJHID.2014.053.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"7","key":"ref6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41408-021-00518-z","article-title":"Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies","volume":"11","author":"Mohty R Dulery R Bazarbachi AH Savani M Hamed RA Bazarbachi A Mohty M","year":"2021","unstructured":"6. Mohty R Dulery R Bazarbachi AH Savani M Hamed RA Bazarbachi A Mohty M Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies Blood Cancer J 2021 Jul 9117126 10.1038\/s41408-021-00518-z","journal-title":"Blood Cancer J"},{"issue":"5","key":"ref7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.3390\/jcm10051125","article-title":"Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients","volume":"10","author":"Momotow J Borchmann S Eichenauer DA Engert A Sasse S","year":"2021","unstructured":"7. Momotow J Borchmann S Eichenauer DA Engert A Sasse S Hodgkin Lymphoma-Review on Pathogenesis, Diagnosis, Current and Future Treatment Approaches for Adult Patients J Clin Med 2021 Mar 81051125 10.3390\/jcm10051125","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"118979","DOI":"10.1016\/j.lfs.2020.118979","article-title":"Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma","volume":"268","author":"Gamboa-Cede\u00f1o AM D\u00edaz M Cristaldo N Otero V","year":"2021","unstructured":"8. Gamboa-Cede\u00f1o AM D\u00edaz M Cristaldo N Otero V  Apoptotic regulator BCL-2 blockade as a potential therapy in classical Hodgkin Lymphoma Life Sci 2021 Mar 1268118979 10.1016\/j.lfs.2020.118979","journal-title":"Life Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"153370","DOI":"10.1016\/j.prp.2021.153370","article-title":"Prognostic value of Bcl2 and p53 in Hodgkin lymphoma: A systematic review and meta-analysis","volume":"219","author":"Travaglino A Russo D Varricchio S Picardi M Mascolo M","year":"2021","unstructured":"9. Travaglino A Russo D Varricchio S Picardi M Mascolo M Prognostic value of Bcl2 and p53 in Hodgkin lymphoma: A systematic review and meta-analysis Pathol Res Pract 2021 Mar219153370 10.1016\/j.prp.2021.153370","journal-title":"Pathol Res Pract"},{"issue":"8","key":"ref10","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/PAS.0b013e31828b6ad3","article-title":"Prognostic significance of COX-2 expression and correlation with Bcl-2 and VEGF expression, microvessel density, and clinical variables in classical Hodgkin lymphoma","volume":"37","author":"Koh YW Park C Yoon DH Suh C Huh J","year":"2013","unstructured":"10. Koh YW Park C Yoon DH Suh C Huh J Prognostic significance of COX-2 expression and correlation with Bcl-2 and VEGF expression, microvessel density, and clinical variables in classical Hodgkin lymphoma Am J Surg Pathol 2013 Aug378124251 10.1097\/PAS.0b013e31828b6ad3","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"ref11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5146\/tjpath.2018.01430","article-title":"Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma","volume":"34","author":"Kili\u00e7arslan A \u00d6zt\u00fcrk V Yikilmaz A\u015e Do\u011fan M Akyol M","year":"2018","unstructured":"11. Kili\u00e7arslan A \u00d6zt\u00fcrk V Yikilmaz A\u015e Do\u011fan M Akyol M Evaluation of the Prognostic Importance of c-Myc and Bcl-2 Expressions and the Presence of Epstein-Barr Virus in Classical Hodgkin Lymphoma Turk Patoloji Derg 2018343199206 English 10.5146\/tjpath.2018.01430","journal-title":"Turk Patoloji Derg"},{"issue":"9","key":"ref12","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00277-015-2403-2","article-title":"Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma","volume":"94","author":"Paydas S Ba\u011f\u0131r E Seydaoglu G Ercolak V Ergin M","year":"2015","unstructured":"12. Paydas S Ba\u011f\u0131r E Seydaoglu G Ercolak V Ergin M Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma Ann Hematol 2015 Sep949154552 10.1007\/s00277-015-2403-2","journal-title":"Ann Hematol"},{"issue":"3","key":"ref13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/JLB.5AB0121-041R","article-title":"PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma","volume":"112","author":"Cuccaro A Bellesi S Galli E Zangrilli I","year":"2022","unstructured":"13. Cuccaro A Bellesi S Galli E Zangrilli I  PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma J Leukoc Biol 2022 Sep1123539545 10.1002\/JLB.5AB0121-041R","journal-title":"J Leukoc Biol"},{"issue":"4","key":"ref14","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/ajh.24272","article-title":"Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management","volume":"91","author":"Ansell SM","year":"2016","unstructured":"14. Ansell SM Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management Am J Hematol 2016 Jun91443442 10.1002\/ajh.24272","journal-title":"Am J Hematol"},{"issue":"13","key":"ref15","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen BJ Chapuy B Ouyang J Sun HH","year":"2013","unstructured":"15. Chen BJ Chapuy B Ouyang J Sun HH  PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies Clin Cancer Res 2013 Jul 11913346273 10.1158\/1078-0432.CCR-13-0855","journal-title":"Clin Cancer Res"},{"issue":"3","key":"ref16","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han Y Liu D Li L","year":"2020","unstructured":"16. Han Y Liu D Li L PD-1\/PD-L1 pathway: current researches in cancer Am J Cancer Res 2020 Mar 1103727742","journal-title":"Am J Cancer Res"},{"issue":"12","key":"ref17","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.1182\/blood-2002-01-0099","article-title":"The role of cytokines in classical Hodgkin lymphoma","volume":"99","author":"Skinnider BF Mak TW","year":"2002","unstructured":"17. Skinnider BF Mak TW The role of cytokines in classical Hodgkin lymphoma Blood 2002 Jun 159912428397 10.1182\/blood-2002-01-0099","journal-title":"Blood"},{"issue":"1","key":"ref18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian BZ Pollard JW","year":"2010","unstructured":"18. Qian BZ Pollard JW Macrophage diversity enhances tumor progression and metastasis Cell 2010 Apr 214113951 10.1016\/j.cell.2010.03.014","journal-title":"Cell"},{"issue":"14","key":"ref19","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.3390\/cancers13143597","article-title":"The Role of Tumor-Associated Macrophages in Hematologic Malignancies","volume":"13","author":"Cencini E Fabbri A Sicuranza A Gozzetti A Bocchia M","year":"2021","unstructured":"19. Cencini E Fabbri A Sicuranza A Gozzetti A Bocchia M The Role of Tumor-Associated Macrophages in Hematologic Malignancies Cancers (Basel) 2021 Jul 1813143597 10.3390\/cancers13143597","journal-title":"Cancers (Basel)"},{"issue":"1","key":"ref20","doi-asserted-by":"publisher","first-page":"9410","DOI":"10.1038\/s41598-020-66010-z","article-title":"Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome","volume":"10","author":"Werner L Dreyer JH Hartmann D Barros MHM","year":"2020","unstructured":"20. Werner L Dreyer JH Hartmann D Barros MHM  Tumor-associated macrophages in classical Hodgkin lymphoma: hormetic relationship to outcome Sci Rep 2020 Jun 101019410 10.1038\/s41598-020-66010-z","journal-title":"Sci Rep"},{"issue":"10","key":"ref21","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.exphem.2011.07.002","article-title":"The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors","volume":"39","author":"J\u00f3na A Khaskhely N Buglio D Shafer JA","year":"2011","unstructured":"21. J\u00f3na A Khaskhely N Buglio D Shafer JA  The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitors Exp Hematol 2011 Oct391010071017.e1 10.1016\/j.exphem.2011.07.002","journal-title":"Exp Hematol"},{"issue":"10","key":"ref22","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa0905680","article-title":"Tumor-associated macrophages and survival in classic Hodgkin's lymphoma","volume":"362","author":"Steidl C Lee T Shah SP Farinha P","year":"2010","unstructured":"22. Steidl C Lee T Shah SP Farinha P  Tumor-associated macrophages and survival in classic Hodgkin's lymphoma N Engl J Med 2010 Mar 113621087585 10.1056\/NEJMoa0905680","journal-title":"N Engl J Med"},{"issue":"3","key":"ref23","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/biomedicines10030579","article-title":"Macrophage Infiltration Correlates with Genomic Instability in Classic Hodgkin Lymphoma","volume":"10","author":"Han\u010di\u0107 S Gr\u0161kovi\u0107 P Ga\u0161parov S Ostoji\u0107 Koloni\u0107 S","year":"2022","unstructured":"23. Han\u010di\u0107 S Gr\u0161kovi\u0107 P Ga\u0161parov S Ostoji\u0107 Koloni\u0107 S  Macrophage Infiltration Correlates with Genomic Instability in Classic Hodgkin Lymphoma Biomedicines 2022 Mar 1103579 10.3390\/biomedicines10030579","journal-title":"Biomedicines"},{"issue":"1","key":"ref24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13000-019-0912-3.","article-title":"The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt","volume":"15","author":"Mohamed O El Bastawisy A Allahlobi N Abdellateif MS","year":"2020","unstructured":"24. Mohamed O El Bastawisy A Allahlobi N Abdellateif MS  The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt Diagn Pathol 2020 Feb 415110 10.1186\/s13000-019-0912-3.","journal-title":"Diagn Pathol"},{"issue":"16","key":"ref25","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1182\/blood-2012-04-421057.","article-title":"Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial","volume":"120","author":"Tan KL Scott DW Hong F Kahl BS","year":"2012","unstructured":"25. Tan KL Scott DW Hong F Kahl BS  Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial Blood 2012 Oct 181201632807 10.1182\/blood-2012-04-421057.","journal-title":"Blood"},{"issue":"8","key":"ref26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.leukres.2014.05.023","article-title":"Insights in Hodgkin Lymphoma angiogenesis","volume":"38","author":"Marinaccio C Nico B Maiorano E Specchia G Ribatti D","year":"2014","unstructured":"26. Marinaccio C Nico B Maiorano E Specchia G Ribatti D Insights in Hodgkin Lymphoma angiogenesis Leuk Res 2014 Aug38885761 10.1016\/j.leukres.2014.05.023","journal-title":"Leuk Res"},{"issue":"1","key":"ref27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/sj.leu.2404402","article-title":"The history of the angiogenic switch concept","volume":"21","author":"Ribatti D Nico B Crivellato E Roccaro AM Vacca A","year":"2007","unstructured":"27. Ribatti D Nico B Crivellato E Roccaro AM Vacca A The history of the angiogenic switch concept Leukemia 2007 Jan2114452 10.1038\/sj.leu.2404402","journal-title":"Leukemia"},{"issue":"6","key":"ref28","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/sj.leu.2403690","article-title":"Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications","volume":"19","author":"Korkolopoulou P Thymara I Kavantzas N Vassilakopoulos TP","year":"2005","unstructured":"28. Korkolopoulou P Thymara I Kavantzas N Vassilakopoulos TP  Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications Leukemia 2005 Jun196894900 10.1038\/sj.leu.2403690","journal-title":"Leukemia"},{"issue":"10","key":"ref29","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1080\/10428190701540975","article-title":"VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues","volume":"48","author":"Bardelli M Leucci E Sch\u00fcrfeld K Bellan C","year":"2007","unstructured":"29. Bardelli M Leucci E Sch\u00fcrfeld K Bellan C  VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues Leuk Lymphoma 2007 Oct4810201421 10.1080\/10428190701540975","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"ref30","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1074\/jbc.M002016200","article-title":"Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants","volume":"276","author":"Gille H Kowalski J Li B LeCouter J","year":"2001","unstructured":"30. Gille H Kowalski J Li B LeCouter J  Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants J Biol Chem 2001 Feb 22765322230 10.1074\/jbc.M002016200","journal-title":"J Biol Chem"},{"issue":"11","key":"ref31","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/emboj\/20.11.2768","article-title":"A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells","volume":"20","author":"Takahashi T Yamaguchi S Chida K Shibuya M","year":"2001","unstructured":"31. Takahashi T Yamaguchi S Chida K Shibuya M A single autophosphorylation site on KDR\/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells EMBO J 2001 Jun 12011276878 10.1093\/emboj\/20.11.2768","journal-title":"EMBO J"},{"issue":"11","key":"ref32","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.3109\/10428194.2013.778405","article-title":"Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma","volume":"54","author":"Panico L Ronconi F Lepore M Tenneriello V Cantore N Dell'Angelo AC Ferbo U Ferrara F","year":"2013","unstructured":"32. Panico L Ronconi F Lepore M Tenneriello V Cantore N Dell'Angelo AC Ferbo U Ferrara F Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma Leuk Lymphoma 2013 Nov5411241825 10.3109\/10428194.2013.778405","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"ref33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3109\/10428194.2013.813629","article-title":"Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma","volume":"55","author":"Dimtsas GS Georgiadi EC Karakitsos P Vassilakopoulos TP","year":"2014","unstructured":"33. Dimtsas GS Georgiadi EC Karakitsos P Vassilakopoulos TP  Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma Leuk Lymphoma 2014 Mar55355864 10.3109\/10428194.2013.813629","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"ref34","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/path.1151","article-title":"Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease","volume":"197","author":"Doussis-Anagnostopoulou IA Talks KL Turley H Debnam P","year":"2002","unstructured":"34. Doussis-Anagnostopoulou IA Talks KL Turley H Debnam P  Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease J Pathol 2002 Aug197567783 10.1002\/path.1151","journal-title":"J Pathol"},{"issue":"12","key":"ref35","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/jcp.2007.050146.","article-title":"Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma","volume":"60","author":"Kapatai G Murray P","year":"2007","unstructured":"35. Kapatai G Murray P Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma J Clin Pathol 2007 Dec601213429 10.1136\/jcp.2007.050146.","journal-title":"J Clin Pathol"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood.V86.4.1493.bloodjournal8641493","article-title":"Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease","volume":"86","author":"Frisan T Sj\u00f6berg J Dolcetti R Boiocchi M","year":"1995","unstructured":"36. Frisan T Sj\u00f6berg J Dolcetti R Boiocchi M  Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease Blood 1995 Aug 158641493501","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1034398","DOI":"10.3389\/fonc.2022.1034398","article-title":"The prognostic value of Epstein-Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis","volume":"12","author":"Hu J Zhang X Tao H Jia Y","year":"2022","unstructured":"37. Hu J Zhang X Tao H Jia Y The prognostic value of Epstein-Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis Front Oncol 2022 Oct 27121034398 10.3389\/fonc.2022.1034398","journal-title":"Front Oncol"},{"issue":"5","key":"ref38","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1054\/bjoc.1999.1049","article-title":"Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents","volume":"82","author":"Alexander FE Jarrett RF Lawrence D Armstrong AA","year":"2000","unstructured":"38. Alexander FE Jarrett RF Lawrence D Armstrong AA  Risk factors for Hodgkin's disease by Epstein-Barr virus (EBV) status: prior infection by EBV and other agents Br J Cancer 2000 Mar825111721 10.1054\/bjoc.1999.1049","journal-title":"Br J Cancer"},{"issue":"1","key":"ref39","doi-asserted-by":"publisher","first-page":"e622","DOI":"10.1038\/bcj.2017.102","article-title":"The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor","volume":"8","author":"Wu R Sattarzadeh A Rutgers B Diepstra A van den Berg A Visser L","year":"2018","unstructured":"39. Wu R Sattarzadeh A Rutgers B Diepstra A van den Berg A Visser L The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor Blood Cancer J 2018 Jan 2681e622 10.1038\/bcj.2017.102","journal-title":"Blood Cancer J"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2023\/issue-8-2023\/original-article-issue-8-2023\/tumor-microenvironment-in-hodgkin-lymphoma-novel-prognostic-factors-for-assessing-disease-evolution\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T03:24:14Z","timestamp":1715397854000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2023\/issue-8-2023\/original-article-issue-8-2023\/tumor-microenvironment-in-hodgkin-lymphoma-novel-prognostic-factors-for-assessing-disease-evolution\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["JMedLife-16-1201"],"URL":"https:\/\/doi.org\/10.25122\/jml-2023-0239","relation":{},"ISSN":["1844-3117"],"issn-type":[{"type":"electronic","value":"1844-3117"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}